Pharmaceuticals

FDA Approves Vericel’s MACI for Arthroscopic Treatment of Cartilage Defects in the Knee

bexib
By bexib 0 Min Read

MACI Arthro can be administered through small incisions using custom instruments to repair cartilage defects in the knee.

You Might Also Like

Braeburn Discusses BRIXADI® Study and Fentanyl’s Impact on OUD

Pharma Pulse 5/10/24: Medicare Advantage, Increased Speed ​​with Competition, Global Strategic Business Report for Anti-Obesity Drugs, and More

Amid weight-loss boom, drug companies seek edge with oral options

Addressing the challenges of myeloma treatment access and advancement

Pharma Pulse 8/5/24: Pharmacists step up RSV care, China aims to launch national internet ID system, and more

Share This Article
Previous Article Former Ambassador Chas Freeman: Civilian government likely to collapse at year’s end
Next Article It is dangerous to ignore probability theory.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Upcoming seller boom for TikTok shops
Retail & E-commerce
The countdown to the reopening of the iconic Delano Miami Beach begins
Hospitality & Tourism
Remembering Maker Faires in 2024?
Manufacturing
Top 5 Open Banking Stories of 2024
Banking